BTC $62,713.13 -1.27%
ETH $1,870.35 -0.82%
BNB $604.15 -0.84%
XRP $1.00 -0.32%
SOL $75.31 -0.90%
TRX $0.3323 -0.51%
DOGE $0.0693 -0.90%
ADA $0.1790 -2.02%
BCH $203.11 -5.10%
LINK $8.77 +0.19%
HYPE $56.09 -2.45%
AAVE $85.75 -2.82%
SUI $0.6764 -1.84%
XLM $0.1595 -0.33%
ZEC $484.16 -1.14%
BTC $62,713.13 -1.27%
ETH $1,870.35 -0.82%
BNB $604.15 -0.84%
XRP $1.00 -0.32%
SOL $75.31 -0.90%
TRX $0.3323 -0.51%
DOGE $0.0693 -0.90%
ADA $0.1790 -2.02%
BCH $203.11 -5.10%
LINK $8.77 +0.19%
HYPE $56.09 -2.45%
AAVE $85.75 -2.82%
SUI $0.6764 -1.84%
XLM $0.1595 -0.33%
ZEC $484.16 -1.14%

US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD

2025-07-19 00:18:45

ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.

Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

app_icon
ChainCatcher Building the Web3 world with innovations.